Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial

2021126 citationsJournal Articlegold Open Access

Authors

ANZGOG1601, ACTRN12617000106336, and NCT03015129.

Good health and well-being

Published in: Journal for ImmunoTherapy of Cancer

Volume 9, Issue 6, pp. e002255-e002255

Field-Weighted Citation Impact: 14.58